Percutaneous Access Closure in TAVR: Are Devices Similar?

One of the challenges that transcatheter aortic valve replacement (TAVR) continues to face is percutaneous access closure with percutaneous closure systems (PCS).

Cierre del acceso percutáneo en TAVI ¿Son similares los dispositivos?

However, several systems have been developed, either by plug—such as the MANTA system—or by suture (SU)—such as the ProStar and ProGlide systems.

Both of these have been tested in different analyses, but to date they are similar and still continue to have certain difficulties.

Researchers conducted a meta-analysis of two randomized and eight observational studies including a total of 3113 patients. Of these, 1358 received the MANTA (43.6%) system, while 1755 received either the ProStar or ProGlide (56.4%) systems.

The primary endpoint (PEP) was major vascular complication according to VARC-2 criteria.

Mean patient age was 80 years old and most subjects were male. Self-expanding valves were used the most, and in most cases heparin was reverted.

Read also: Have Complications Related to Balloon Pulmonary Angioplasty Changed Since its Inception?

There were no differences in the PEP (3.1% vs. 3.3 %; odds ratio [OR]: 0.89; 95% confidence interval [CI]: 0.52−1.53; p = 0.67).

The PCS failure rate was lower in the PL D group (6.2% vs. 8.9 %; OR: 0.60; 95% CI: 0.44−0.83; p = 0.002; I2 = 14%). However, in this group there was a greater trend towards unplanned vascular access intervention (8.2% vs. 5.9 %; OR: 1.35; 95% CI: 0.97−1.89; p = 0.07; I2 = 3%).

There were no differences in the rates for mortality, bleeding (major, minor or life-threatening), transfusion, bruising, pseudoaneurysm, lower limb ischemia, or arteriovenous fistulae.

Read also: Prosthesis Mismatch in TAVR: It’s Real Impact.

In randomized trials, the rates of bleeding, major bleeding, and minor vascular complications were lower in those who received a plug PCS vs. SU PCS.

Conclusion

In patients undergoing TAVR, closure using plug-based PCSs was associated with a similar safety profile than SU-based PCSs. However, subgroup analysis demonstrated that the plug-based PCSs were associated with a higher incidence of vascular and bleeding complications in randomized studies.

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Outcomes with plug‐based versus suture‐based vascular closure device after transfemoral transcatheter aortic valve replacement: A systematic review and meta‐analysis.

Reference: Ramy Sedhom MD, et al. Catheter Cardiovasc Interv. 2023;101:817–827.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Even though percutaneous left atrial appendage (LAA) closure is generally safe, device embolization – with 0 to 1.5% global incidence – is still a...

Cardiac Remodeling After Percutaneous ASD Closure: Should It Be Immediate or Progressive?

Atrial septal defect (ASD) is a common congenital heart disease that generates a left-to-right shunt, leading to right-side chamber overload and a risk of...

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains...

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Coronary artery disease (CAD) in smaller epicardial vessels occurs in 30% to 67% of patients undergoing percutaneous coronary intervention and poses particular technical challenges....

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Even though percutaneous left atrial appendage (LAA) closure is generally safe, device embolization – with 0 to 1.5% global incidence – is still a...